Lielbritānija - angļu - VMD (Veterinary Medicines Directorate)

merial animal health limited - porcine respiratory and reproductive syndrome virus - emulsion for injection - inactivated viral vaccine - pigs

Lielbritānija - angļu - VMD (Veterinary Medicines Directorate)

ceva animal health ltd - porcine respiratory and reproductive syndrome virus - emulsion for injection - inactivated viral vaccine - pigs

Lielbritānija - angļu - VMD (Veterinary Medicines Directorate)

ceva animal health ltd - porcine respiratory and reproductive syndrome virus - emulsion for injection - inactivated viral vaccine - pigs

Lielbritānija - angļu - VMD (Veterinary Medicines Directorate)

ceva animal health ltd - porcine respiratory and reproductive syndrome virus - emulsion for injection - inactivated viral vaccine - pigs

Filipīnas - angļu - FDA (Food And Drug Administration)

metro drug, inc.; distributor: metro drug, inc. - porcine reproductive and respiratory syndrome (prrs) virus antibody test kit (vet.) - none - none

Filipīnas - angļu - FDA (Food And Drug Administration)

metro drug, inc.; distributor: metro drug, inc. - porcine reproductive and respiratory syndrome (prrs) virus antibody test kit (vet.) - none - none

Izraēla - angļu - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - rotavirus g1 reassortant; rotavirus g2 reassortant; rotavirus g3 reassortant; rotavirus g4 reassortant; rotavirus p1a[8] reassortant - oral solution - rotavirus p1a[8] reassortant 2.3 x10 ^6 iu/dose; rotavirus g2 reassortant 2.8 x10 ^6 iu/dose; rotavirus g4 reassortant 2.0 x10^ 6 iu/dose; rotavirus g3 reassortant 2.2 x10 ^6 iu/dose; rotavirus g1 reassortant 2.2 x10 ^6 iu/dose - rota virus diarrhea vaccines - rotateq is indicated for the prevention of rotavirus gastroenteritis in infants and children caused by types g1, g2, g3, g4, and g9 when administered as a 3-dose series to infants between the ages of 6 to 32 weeks. the first dose of rotateq should be administered between 6 and 12 weeks of age

Lielbritānija - angļu - VMD (Veterinary Medicines Directorate)

laboratorios hipra sa - porcine respiratory and reproductive syndrome virus - lyophilisate and solvent for solution for injection - live viral vaccine - pigs

Lielbritānija - angļu - VMD (Veterinary Medicines Directorate)

boehringer ingelheim ltd - porcine respiratory and reproductive syndrome virus -

Eiropas Savienība - angļu - EMA (European Medicines Agency)

zoetis belgium sa - modified live porcine respiratory and reproductive syndrome virus - immunologicals for suidae, live viral vaccines - pigs - for active immunisation of clinically healthy pigs from 1 day of age in a porcine respiratory and reproductive syndrome (prrs) virus contaminated environment, to reduce viraemia and nasal shedding caused by infection with european strains of prrs virus (genotype 1).fattening pigs: in addition, vaccination of seronegative 1-day-old piglets was demonstrated to significantly reduce lung lesions against challenge administered at 26 weeks post vaccination. vaccination of seronegative 2-week-old piglets was demonstrated to significantly reduce lung lesions and oral shedding against challenge administered at 28 days and at 16 weeks post-vaccination.gilts and sows: in addition, pre-pregnancy vaccination of clinically healthy gilts and sows, either seropositive or seronegative, was demonstrated to reduce the transplacental infection caused by prrs virus during the third trimester of pregnancy, and to reduce the associated negative impact on reproductive performance (reduction of the occurrence of stillbirths, of piglet viraemia at birth and at weaning, of lung lesions and of viral load in lungs in piglets at weaning).